11-58402489-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005469.2(OR5B3):c.921A>T(p.Lys307Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000368 in 1,609,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005469.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5B3 | NM_001005469.2 | c.921A>T | p.Lys307Asn | missense_variant | 2/2 | ENST00000641865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5B3 | ENST00000641865.1 | c.921A>T | p.Lys307Asn | missense_variant | 2/2 | NM_001005469.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152144Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000156 AC: 39AN: 250708Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135470
GnomAD4 exome AF: 0.000390 AC: 569AN: 1457284Hom.: 0 Cov.: 29 AF XY: 0.000400 AC XY: 290AN XY: 725242
GnomAD4 genome AF: 0.000158 AC: 24AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.921A>T (p.K307N) alteration is located in exon 1 (coding exon 1) of the OR5B3 gene. This alteration results from a A to T substitution at nucleotide position 921, causing the lysine (K) at amino acid position 307 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at